Comparison of Omeprazol blood level in granule & syrup form in children by high performance liquid chromatography (HPLC)

Comparison of Omeprazol blood level in using granule and syrup form in children by high performance liquid chromatography (HPLC)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201009154746N1

Enrollment

Registered

2010-11-26

Start date

2009-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Acid peptic disease. Condition 2: Acid peptic disease. Oesophagitis Gastritis and duodenitis

Interventions

Intervention 1: Omeprazol syrup(2mg/ml) 1mg/kg/day. Intervention 2: Omeprazol granule 1mg/kg/day.

Treatment - Drugs

Omeprazol syrup(2mg/ml) 1mg/kg/day

Omeprazol granule 1mg/kg/day

Eligibility

Sex/Gender

All

Age

1 Years to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patient with acid peptic disease who needed Omeprazol. Exclusion Criteria: Blood sample not available.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Omeprazol blood level. Timepoint: 0.5 hour before dosing and 2 houre affter dosing. Method of measurement: HPLC System.	—

Secondary

Measure	Time frame
Clinical effect. Timepoint: 2 weeks. Method of measurement: by physician.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. GH. Dehghanzadeh

Shiraz university of medical sciencses

ghdehghan@sums.ac.ir , fooddrug2001@yahoo.com+98 71 1242 5416

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026